V.MED DRIVE 300
V.MED DRIVE 300(225MG BOLDENONE UNDECYLENATE AND 75MG METHANDRIOL DIPROPIONATE MIX)
METHANDRIOL BOLDENONE UNDECYCLENATE(DRIVE)
Active-Life: Boldenone-7-8 day/Methandriol 2-3 days
Drug Class: Anabolic/Androgenic injectable steroid mixture
Average Reported Dosage: Men: 6-12 ml weekly Women 3-6ml weekly
Acne: Yes (due to Methandriol)
Water Retention: Moderate
High Blood Pressure: Dosage dependent
Liver Toxic: Low-moderate (only due to methandriol)
DHT Conversion: Low
Decreases HPTA function: Yes, low to moderately (dose dependent)
This is a veterinary steroid manufactured in Australia containing a mixture of two steroids: Boldenone Undecylenate (Equipoise/EQ) and Methandriol Dipropionate (MD). The combination provided a highly anabolic and androgenic mixture that, due to Methandriol, had a high receptor-site affinity and caused some water retention for users. It was reported as only slightly liver toxic and noted that it decreased HPTA function moderately in higher dosages. The combination was quite effective for building high quality muscle mass while causing continuous gains in strength and weight. The resulting quality "lean tissue" was retained post-cycle reasonably well considering the estrogenic effects of MD. This drug did not cause a rapid build- up in strength or mass like testosterone, but provided long term progress quite well. Males divided injections into 37 administrations weekly with reported best results from daily administration. This was likely due to methandriol's relatively short active-life. Like all products containing boldenone or methandriol, Pace was said to stack well with almost any anabolic product.
*Another similar veterinary AAS is Tribolin 75. This is a mixture of Nandrolone Decanoate (Deca) and Methandriol Dipropionate in equal ratios, providing 75mg/ml
STANDARD TESTOSTERONE PROPIONATE
Active-Life: 2-3 days injectable/ 4-6 hours orals Drug Class: Anabolic/Androgenic Steroid
Average Reported Dosage: Tabs- men 40-60mg daily, injectable 100-mg every 2-3 days.
Water Retention: High
High Blood Pressure: Yes
Liver Toxic: Injectable- Moderate /Oral-yes due to higher dosage requirements
Noted Comments: Strong Anabolic/Strong Androgenic/Estrogenic activity
DHT Conversion: Unknown
Decreases HPTA function: Yes, significantly
MD is a highly Anabolic/Androgenic steroid with unique reported quality of improving receptor affinity for/with other anabolic/androgenic compounds. It provided good muscle mass gains with good strength gains while causing high water retention. While the injection form was "said" to be easy on the liver, the tablet form is highly liver toxic due to its 17-alfa-alkylated structure. Males normally injected 100 mg every second or third day, or ingested 300-600mg in divided daily dosages. Even after only 4 weeks of use the orals can cause liver problems. The injectable form of MD is also available in combination with other steroids. These are the Australian veterinary drugs: Drive, Filibol Forte, Geldabol, and Spectriol.
Something I liked about MD was its noted ability to clean out androgen receptor-sites. Often individuals who had experienced so called receptor burn-out finally utilized an MD product to discover new gains. DNP does this as well, but in a different manner. When utilizing site -injection protocols, MD was an excellent addition for me. Many have obviously reported improved growth stacking MD with other AAS. It should be noted that the drug MD is similar in structure to a weak estrogen. This means higher dosage use can lead to estrogenic side effects.
*Since both oral and injection forms of MD are c17-alkylated it seems obvious that both are potentially liver toxic though the latter possesses a lower potential due to dosage administered in comparison.